We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Try the New Site
We're building a modernized ClinicalTrials.gov! Visit Beta.ClinicalTrials.gov to try the new functionality.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02601313
Brief Title: Study of Brexucabtagene Autoleucel (KTE-X19) in Participants With Relapsed/Refractory Mantle Cell Lymphoma (Cohort 1 and Cohort 2) (ZUMA-2)
First Submitted : November 6, 2015
First Submitted that Met QC Criteria : November 6, 2015
First Posted : November 10, 2015 (Estimate)
Results First Submitted : August 21, 2020
Results First Submitted that Met QC Criteria : August 21, 2020
Results First Posted : September 10, 2020
Certification/Extension First Submitted : July 17, 2020
Certification/Extension First Submitted that Met QC Criteria : July 17, 2020
Certification/Extension First Posted : July 21, 2020
Last Update Submitted that Met QC Criteria : March 22, 2023
Last Update Posted : March 24, 2023